About this trial
The objective of this study is to estimate the feasibility and safety of early weaning from ICU treatment in patients after cardiac arrest and an early (\< 12 h) favourable EEG pattern (indicating no or mild postanoxic encephalopathy).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients after cardiac arrest admitted to the ICU for treatment with sedation, TTM and mechanical ventilation.
Age 18 years or older.
Continuous EEG measurement started within 12 hours after cardiac arrest.
Favourable EEG pattern within 12 hours after arrest, defined as a continuous background pattern (NVN, 2019; Ruijter et al., 2019).
Disqualifiers
A known history of another medical condition with limited life expectancy (<6 months).
Any progressive brain illness, such as a brain tumour or neurodegenerative disease.
Pre-admission Glasgow Outcome Scale Extended score of 4 or lower.
Reason other than neurological condition to continue sedation and/or ventilation.
Trial design
Parallel
Treatments tested in this trial
Early cessation of sedation and TTM
Other interventionEarly cessation of sedation and TTM, with subsequent weaning from mechanical ventilation if appropriate
Treatment groups
Trial outcomes
Primary outcomes
Mechanical ventilation time in hours
Secondary outcomes
Length of ICU stay
Total sedation time
Need for re-intubation
Need for restarting sedation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.